Han Min Ho, Jeong Ji-Suk, Jeong Jin-Woo, Choi Sung Hyun, Kim Sung Ok, Hong Su Hyun, Park Cheol, Kim Byung Woo, Choi Yung Hyun
National Marine Biodiversity Institute of Korea.
Gurye Wild Flower Institute and Gurye-gun Agricultural Center.
Drug Discov Ther. 2017 Nov 22;11(5):281-287. doi: 10.5582/ddt.2017.01046. Epub 2017 Oct 11.
The leaves of Aster yomena (Kitam.) Honda have long been used as a traditional herb for treating disorders including coughs, asthma, and insect bites. According to recent studies, A. yomena leaf extracts have several pharmacological properties, including anti-inflammatory, antioxidant, and anti-asthmatic activities. However, little information is available regarding their anti-obesity effect. In this study, we investigated the inhibitory effect of the ethanol extracts of A. yomena leaves (EEAY) on adipocyte differentiation and adipogenesis using 3T3-L1 preadipocytes. When 3T3-L1 preadipocytes were treated with various concentrations of EEAY (ranging from non-toxic), the number of lipid droplets, lipid content, and triglyceride production, the typical characteristics of adipocytes, were suppressed in a concentration-dependent manner. During this process, EEAY significantly reduced the expression of adipogenic transcription factors, including peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding protein α and β, and sterol regulatory element-binding protein-1c. In addition, EEAY was also found to potently inhibit the expression of adipocyte-specific genes, including adipocyte fatty acid-binding protein and leptin. In particular, EEAY treatment effectively enhanced the activation of the AMP-activated protein kinase (AMPK) signaling pathway; however, the co-treatment with compound C, an inhibitor of AMPK, significantly restored the EEAY-induced inhibition of pro-adipogenic transcription factors and adipocyte-specific genes. These results indicate that EEAY may exert an anti-obesity effect by controlling the AMPK signaling pathway, suggesting that the leaf extract of A. yomena may be a potential anti-obesity agent.
早开紫菀(Aster yomena (Kitam.) Honda)的叶子长期以来一直被用作传统草药,用于治疗咳嗽、哮喘和蚊虫叮咬等疾病。根据最近的研究,早开紫菀叶提取物具有多种药理特性,包括抗炎、抗氧化和抗哮喘活性。然而,关于其抗肥胖作用的信息却很少。在本研究中,我们使用3T3-L1前脂肪细胞研究了早开紫菀叶乙醇提取物(EEAY)对脂肪细胞分化和脂肪生成的抑制作用。当用不同浓度的EEAY(无毒范围)处理3T3-L1前脂肪细胞时,脂滴数量、脂质含量和甘油三酯生成(脂肪细胞的典型特征)以浓度依赖的方式受到抑制。在此过程中,EEAY显著降低了脂肪生成转录因子的表达,包括过氧化物酶体增殖物激活受体-γ、CCAAT/增强子结合蛋白α和β以及固醇调节元件结合蛋白-1c。此外,还发现EEAY能有效抑制脂肪细胞特异性基因的表达,包括脂肪细胞脂肪酸结合蛋白和瘦素。特别是,EEAY处理有效地增强了AMP激活蛋白激酶(AMPK)信号通路的激活;然而,与AMPK抑制剂化合物C共同处理显著恢复了EEAY诱导的对促脂肪生成转录因子和脂肪细胞特异性基因的抑制作用。这些结果表明,EEAY可能通过控制AMPK信号通路发挥抗肥胖作用,提示早开紫菀叶提取物可能是一种潜在的抗肥胖药物。